ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

vaccineSubscribe to vaccine

COVID-19 Vaccine Accessibility

The patent waiver procedure at the World Trade Organization needs to be fast-tracked. The global community must not be constrained by the interests of private industry and saving lives is what matters.

Why India’s Vaccine Companies Are Profiteering in the Pandemic

The crisis of COVID-19 vaccines in India is a consequence of government policies dating back decades. Private foundations led by the Bill and Melinda Gates Foundation have engineered a shift in research and manufacture of essential technologies such as vaccines to private biotech labs and factories. Companies such as the Serum Institute of India and Bharat Biotech can dictate terms and prices of vaccines developed with public support because the closure of public vaccine manufacturing units over a decade ago has left the government at the mercy of the private sector.

Of Vaccine Shortages and Transparency

The government’s narrative on vaccination should reflect sincerity, truth and transparency.

Emergency Use Authorisation of COVID-19 Vaccines

In granting EUA to vaccines, both urgency and adherence to protocol should be taken into consideration.

Process of a Vaccine Trial

This paper describes the complex process of a clinical trial of Mw anti-leprosy vaccine. The receivers of the bio-medical products are viewed not as mere cases seen through the protocol of the trial but as persons within different social contexts with their own understanding of the product in relation to their bodies. The issue becomes more complex in the case of the Mw vaccine as it is not only a prophylactic but also a therapeutic vaccine the patients negotiate between their understanding of the disease and the product. This also influences the biomedical discourse as the clinicians have to negotiate a balance between the therapeutic and experimental aspects of their work.
Back to Top